The Midwest Neuroscience Institute at Menorah Medical Center is committed to providing the highest level of patient care through the most advanced diagnosis and treatment technologies available.
In addition standard technologies, such as MRI, ultrasound, CT, and X-ray, our patients have access to some of today’s most leading-edge technologies, such as:
- CyberKnife® technology
- The Neuroblate® System
- The TrueBeam™ Linear Accelerator System
- STAR™ Tumor Ablation System
The Midwest Neuroscience Institute at Menorah Medical Center was the first in the Kansas City area to offer CyberKnife® technology, a painless radiation treatment that can be an alternative to open surgery in many cases. Delivering a focused beam of high-energy radiation from 1,600 angles, CyberKnife® precisely targets cancer cells and avoids damage to nearby healthy tissue.
Other benefits of CyberKnife® radiation treatment:
- Non-invasive – no blood loss
- No pain
- No anesthesia required
- Immediate return to normal activity
- Ability to treat multiple tumors in different locations at the same time
The Neuroblate® System is a minimally invasive tool that uses MRI-guided technology to precisely target and ablate diseased cells in the brain, including some that may have traditionally been deemed "inoperable." It is the only system that monitors ablation contours in 3-D and provides real-time imaging to guide the surgeon.
The TrueBeam™ system brings leading-edge cancer care to the Midwest Neuroscience Institute at Menorah Medical Center by positioning our Sarah Cannon Cancer Institute at the forefront in the fight against cancer. Delivering numerous radiotherapy treatment techniques, TrueBeam™ provides clinicians with the opportunity to address a diverse range of cancer cases from cranial, head and neck, to lung and spine and tailor treatment plans for each patient. TrueBeam™ addresses the technical challenges of these four common cancer types:
- Head and neck